cysteine has been researched along with THZ531 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, BJ; Bartkowiak, B; Bullock, AN; Dixon-Clarke, SE; Elkins, JM; Ficarro, SB; Geyer, M; Gray, NS; Greenleaf, AL; Greifenberg, AK; Hannett, NM; Hao, M; Kwiatkowski, N; Liang, Y; Manz, T; Marto, JA; Olson, CM; Young, RA; Zhang, T | 1 |
1 other study(ies) available for cysteine and THZ531
| Article | Year |
|---|---|
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.
Topics: Anilides; CDC2 Protein Kinase; Cell Death; Cyclin-Dependent Kinases; Cysteine; DNA Damage; Humans; Protein Kinase Inhibitors; Pyrimidines | 2016 |